This inventor holds 4 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Leap Therapeutics, Inc., Tensha Therapeutics, Inc.. Active years: 2018-2025.
Company Filing History:
Years Active: 2018-2025
Title: Michael H Kagey: Innovator in Cancer Treatment
Introduction
Michael H Kagey is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of cancer treatment, holding a total of 4 patents. His work focuses on innovative methods for treating various types of cancers, showcasing his dedication to advancing medical science.
Latest Patents
One of Kagey's latest patents involves the use of beta-catenin as a biomarker for treating cancers with an anti-Dkk-1 antibody. This method is designed for subjects diagnosed with esophageal cancer, uterine cancer, liver cancer, or cholangiocarcinoma. The treatment comprises administering an effective amount of an anti-Dkk-1 antibody or its antigen-binding fragment to patients who have a constitutively activating mutation of the beta-catenin protein. This innovative approach highlights Kagey's commitment to improving cancer therapies.
Career Highlights
Throughout his career, Michael H Kagey has worked with several prominent companies in the biotechnology sector. Notable among these are Tensha Therapeutics, Inc. and Leap Therapeutics, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Kagey has had the opportunity to work alongside esteemed colleagues such as Steven B Landau and Cynthia A Sirard. These collaborations have further enriched his research and development efforts in cancer treatment.
Conclusion
Michael H Kagey stands out as an influential inventor in the realm of cancer treatment. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.